Literature DB >> 33404691

Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients.

Hiroki Hosoi1, Shogo Murata2, Toshiki Mushino2, Shinobu Tamura2, Takashi Sonoki2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33404691     DOI： 10.1007/s00277-020-04373-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  10 in total

1.  Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.

Authors:  Rebecca L Elstrom; Peter Martin; Sandra Hurtado Rua; Tsiporah B Shore; Richard R Furman; Jia Ruan; Roger N Pearse; Morton Coleman; Tomer Mark; John P Leonard; Usama Gergis
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

2.  Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over.

Authors:  D J Andorsky; M Cohen; A Naeim; L Pinter-Brown
Journal:  Bone Marrow Transplant       Date:  2010-12-13       Impact factor: 5.483

3.  BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.

Authors:  M D Caballero; V Rubio; J Rifon; I Heras; R García-Sanz; L Vázquez; B Vidriales; M C del Cañizo; M Corral; M Gonzalez; A León; E Jean-Paul; E Rocha; J M Moraleda; J F San Miguel
Journal:  Bone Marrow Transplant       Date:  1997-09       Impact factor: 5.483

4.  Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study.

Authors:  Marina Davidov; Chava Perry; Yair Herishanu; Nadav Sarid; Esti Rom; Odelia Amit; Rinat Eshel; Ella Naparstek; Irit Avivi; Ron Ram
Journal:  Ann Hematol       Date:  2017-11-25       Impact factor: 3.673

5.  High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.

Authors:  Dai Chihara; Koji Izutsu; Eisei Kondo; Rika Sakai; Shuichi Mizuta; Kenji Yokoyama; Hiroto Kaneko; Koji Kato; Yuichi Hasegawa; Takaaki Chou; Hiroyuki Sugahara; Hideho Henzan; Hisashi Sakamaki; Ritsuro Suzuki; Junji Suzumiya
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-31       Impact factor: 5.742

6.  Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation.

Authors:  C Girouard; J Dufresne; K Imrie; A K Stewart; J Brandwein; H M Prince; D Pantolony; A Keating; M Crump
Journal:  Ann Oncol       Date:  1997-07       Impact factor: 32.976

7.  Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.

Authors:  Lova Sun; Shuli Li; Areej El-Jawahri; Philippe Armand; Bimalangshu R Dey; David C Fisher; Eric D Jacobsen; Caron A Jacobson; Ann S LaCasce; Steven L McAfee; Thomas R Spitzer; Yi-Bin Chen; Zachariah DeFilipp
Journal:  Oncologist       Date:  2017-12-28

8.  Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study.

Authors:  E Hermet; A Cabrespine; R Guièze; A Garnier; A Tempescul; P Lenain; R Bouabdallah; J P Vilque; J Frayfer; D Bordessoule; D Sibon; M Janvier; D Caillot; P Biron; L Legros; B Choufi; B Drenou; N C Gorin; K Bilger; J Tamburini; C Soussain; S Brechignac; J O Bay
Journal:  J Geriatr Oncol       Date:  2015-06-23       Impact factor: 3.599

9.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

10.  Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.

Authors:  Parastoo B Dahi; Roni Tamari; Sean M Devlin; Molly Maloy; Valkal Bhatt; Michael Scordo; Jenna Goldberg; Andrew D Zelenetz; Paul A Hamlin; Matthew J Matasar; Jocelyn Maragulia; Sergio A Giralt; Miguel-Angel Perales; Craig H Moskowitz; Craig S Sauter
Journal:  Biol Blood Marrow Transplant       Date:  2014-08-28       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.